Today we are a global medical IP innovation incubator and consultancy firm that provides medical product sales.
A proven and successful commercialization model
IntuitiveX was founded with the goal of developing and commercializing emerging technologies within healthcare and life sciences.
Building next-generation medical companies.
We trace our history back to March 15, 2016, when three long-term friends turned founders discovered a huge opportunity to de-risk and commercialize early-stage medical innovations.
A year later they met IP pioneer, John Cronin, and realized bridging the world of IP, high-technology, and healthcare is a much bigger opportunity and through utilizing a proprietary brainstorming and IP landscaping method, novel intellectual property and technologies can be developed and commercialized.
Our history marries the worlds of healthcare, IP, and high-technology commercialization.
We serve as a trusted innovation partner for the ideation, commercialization, and growth of ideas, to catalyze breakthroughs within healthcare.
Operating from the USA
Today we are a global medical IP innovation incubator and consultancy firm that provides medical product sales.
IntuitiveX was founded with the goal of developing and commercializing emerging technologies within healthcare and life sciences.
Building next-generation medical companies.
We trace our history back to March 15, 2016, when three long-term friends turned founders discovered a huge opportunity to de-risk and commercialize early-stage medical innovations.
A year later they met IP pioneer, John Cronin, and realized bridging the world of IP, high-technology, and healthcare is a much bigger opportunity and through utilizing a proprietary brainstorming and IP landscaping method, novel intellectual property and technologies can be developed and commercialized.
Our history marries the worlds of healthcare, IP, and high-technology commercialization.
We serve as a trusted innovation partner for the ideation, commercialization, and growth of ideas, to catalyze breakthroughs within healthcare.
Operating from the USA
OUR SUCCESS
Amplify Surgical - Raised a $6M Series A round within 12 weeks
Chiral Surgical acquired by CTL Amedica
NavLab Holdings successfully sold multiple IP assets to Large MedTech multinational corporations for an undisclosed amount generating IRR +180%
Altpep Corporation - Raised Series A +$23.1M, received FDA Breakthrough Device Designation
Carlsmed (acquired Precisive Surgical) - Raised Series A +$12.6M, Received Breakthrough Device Designation from the FDA, and prestigious NTAP reimbursement
IX Innovation LLC - Raised $900,000 Seed Round (Oversubscribed by $400,000)